Library

Fenozolón

Developed as 'Ordinator' by Laboratoires Dausse in France during the 1960s for treatment of psychasthenia. Fenozolone is structurally related to pemoline and acts as a norepinephrine-dopamine releasing agent with weaker serotonin activity. Clinical imaging studies demonstrate focused sensorimotor activation comparable to fluoxetine with greater sympathetic arousal. Community reports suggest optimal doses of 15-25 mg oral for focused stimulation with minimal anxiety. Higher doses above 40 mg significantly increase cardiovascular strain and anxiety.

Fenozolón molecular structure
Fenozolón molecular structure diagram from the DrugsPRO substance library.

Also known as: Ld-3394, Ordinator

Classification

  • Chemical: Aminorex
  • Psychoactive: Stimulant
  • Tag: 4-oxazolidinone
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Increased Heart Rate
  • Vasoconstriction
  • Physical Euphoria
  • Stamina Enhancement
  • Loss Of Appetite
  • Focus Enhancement
  • Motivation Enhancement
  • Wakefulness
  • Euphoria
  • Anxiety
  • Thought Acceleration
  • Appetite Suppression
  • Light Sensitivity
  • Bodily Control Enhancement
  • Increased Libido
  • Increased Music Appreciation
  • Dehydration

Routes of Administration

Oral

Dosage

  • Threshold: 5 mg
  • Light: 5-15 mg
  • Common: 15-30 mg
  • Strong: 30-50 mg
  • Heavy: 50 mg

Duration

  • Onset: 0.25-0.75 h
  • Comeup: 0.5-1 h
  • Peak: 1-3 h
  • Offset: 1-2 h
  • After Effects: 2-12 h

Insufflated

Dosage

  • Threshold: 5 mg
  • Light: 5-10 mg
  • Common: 10-20 mg
  • Strong: 20-35 mg
  • Heavy: 35 mg

Duration

  • Onset: 0.08-0.17 h
  • Comeup: 0.25-0.5 h
  • Peak: 1-3 h
  • Offset: 1-2 h
  • After Effects: 2-12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Fenozolone - DrugsPRO sprievodca látky

Fenozolone: Developed as 'Ordinator' by Laboratoires Dausse in France during the 1960s for treatment of psychasthenia. Fenozolone is structurally related to pemoline and acts as a norepinephrine-dopamine releasing agent with weaker serotonin activity. Clinical imaging studies demonstrate focused sen

Related pages